Related Experiment Video
Updated: Oct 25, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
Multiple direction needle-path planning and inverse dose optimization for robotic low-dose rate brachytherapy
Philipp Aumüller1, Andreas Rothfuss2, Martin Polednik1
1Department of Radiation Oncology, University Medical Centre Mannheim, University Heidelberg, Germany.
Zeitschrift Fur Medizinische Physik
|August 10, 2021
Summary
This study introduces a novel treatment planning system (TPS) for robotic-assisted low-dose-rate brachytherapy, enhancing precision and safety. The system optimizes needle placement and dose distribution, achieving excellent coverage and reducing planning time.
Area of Science:
- Medical Physics
- Radiation Oncology
- Robotics in Medicine
Background:
- Robotic systems offer potential for precise needle placement in brachytherapy.
- Current systems are limited by path planning around critical structures.
- Conformal dose planning requires advanced optimization algorithms.
Purpose of the Study:
- To develop and evaluate a treatment planning system (TPS) integrating multi-directional needle-path planning with inverse dose optimization for low-dose-rate brachytherapy.
- To enable conformal dose planning by overcoming limitations of path planning around risk structures.
Main Methods:
- Investigated a path planning algorithm to identify optimal needle trajectories avoiding critical structures.
- Developed a modular inverse radiation plan optimization algorithm including greedy, remove-seed, depth, and coverage optimizers.
- Benchmarked dose calculation and inverse optimization using a phantom liver metastasis model and compared with a commercial TPS via global gamma analysis.
Main Results:
- Path planning algorithm reduced potential injection points by 72.5%.
- Global gamma analysis (1%=2.9Gy, 1mm) achieved a 98.5% pass rate, indicating good agreement with commercial TPS.
- Achieved excellent dose coverage (V100=99.1±0.3%, D90=125.9±3.6Gy) with 10.7±1.3 needles and 34.0±0.8 seeds in a median TPS running time of 4.4 minutes.
Conclusions:
- The developed TPS generates clinically acceptable treatment plans efficiently.
- The system demonstrates good agreement with commercial TPS, validating its accuracy.
- This TPS leverages robotic navigation for precise, safe, and minimally invasive low-dose-rate brachytherapy.

